Ampio Pharma (NYSE: AMPE) was mentioned cautiously in connection with ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Trader Talk

Needham & Company Cuts Price Target on Flexion Therapeutics (FLXN) Following Top-Line FX006 Data September 9, 2015 7:41 AM Flexion Therapeutics (FLXN) Announces First Phase 2b of FX006 in OA Knee Pain Missed Primary EndpointSeptember 8, 2015 4:07 PM Flexion Therapeutics Reports Top-Line Data From Pivotal Phase 2b Clinical Trial for FX006September 8, 2015 4:01 PM